CDKN2A and hepatocellular carcinoma: In fact, mechanistically, miR-218 inhibits cell growth and induces G1-phase arrest by directly suppressing Bmi-1 expression, thereby activating the P14ARF-P53 and P16Ink4a-Rb signaling pathways in HCC [140].